Key Finding
Dracorhodin perchlorate significantly reduced inflammatory proteins IL-6 and CINC-3 while increasing nerve-protective CNTF, demonstrating dual anti-inflammatory and neurotrophic effects in sciatic nerve injury.
Researchers investigated a traditional Chinese herbal compound called dracorhodin perchlorate (DP) as a potential treatment for sciatic nerve pain. Using rats with chronic nerve injury that mimics human sciatica, scientists compared animals that received DP treatment against untreated controls, examining protein changes in their tissues at 1, 3, and 7 days after treatment.
The study found that DP produced three important effects on the injured nerves. First, it significantly reduced levels of two inflammatory proteins (IL-6 and CINC-3) that contribute to pain and swelling. Second, it increased production of a beneficial protein called CNTF that helps nerves heal and regenerate. Third, it prevented immune cells called neutrophils from migrating to the injury site, which reduces harmful inflammation. These findings were confirmed through multiple laboratory techniques including protein analysis and additional experiments using zebrafish.
For patients suffering from sciatica, this research helps explain how certain herbal compounds traditionally used in Chinese medicine may work at the molecular level. The study suggests that DP addresses sciatica through two complementary mechanisms: reducing inflammation that causes pain, while simultaneously promoting nerve repair and regeneration. This dual action may offer advantages over treatments that only address one aspect of the condition. While this research was conducted in animals and requires human clinical trials before drawing definitive conclusions, it provides scientific support for the anti-inflammatory and nerve-protective properties of traditional herbal approaches to sciatic pain. Patients interested in herbal medicine or acupuncture for sciatica should consult with a licensed acupuncturist or qualified traditional Chinese medicine practitioner to discuss appropriate treatment options.
This preclinical study examined dracorhodin perchlorate (DP) efficacy in treating sciatic nerve pain using a rat chronic constriction injury (CCI) model. Protein sequencing analysis compared control (CCI only) versus DP-treated groups at 1, 3, and 7-day intervals post-treatment. Key findings demonstrated DP significantly downregulated inflammatory mediators IL-6 and CINC-3 while upregulating ciliary neurotrophic factor (CNTF). Functional enrichment analysis revealed these differentially expressed proteins primarily affect inflammatory signaling pathways, nerve repair mechanisms, and neutrophil chemotaxis. Western blot and ELISA validation confirmed these protein expression changes. Zebrafish inflammation model experiments corroborated DP's ability to inhibit neutrophil recruitment and migration. Clinical significance: DP demonstrates dual therapeutic action through anti-inflammatory effects (via IL-6/CINC-3 suppression and neutrophil inhibition) combined with neurotrophic promotion (via CNTF upregulation), suggesting potential for treating sciatica by addressing both pain pathways and nerve regeneration simultaneously. These mechanisms provide molecular evidence supporting traditional herbal approaches to peripheral neuropathic pain conditions.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Each 1-unit increase in Dietary Inflammatory Index scores was associated with a 0.48-point increase in pain and 4.75-point increase in disability among sciatica patients, effects not mediated by C-reactive protein.
📌 Fu's Subcutaneous Needling demonstrated superior pain relief compared to traditional acupuncture in sciatica by upregulating the PINK1/Parkin mitochondrial autophagy pathway and reducing inflammatory markers.
📌 Acupotomy combined with epidural steroid injection was both more effective and less costly than epidural steroid injection alone, producing better quality of life outcomes while reducing total costs by $147 per patient over 8 weeks.